
Multiple myeloma is a rare blood malignancy that affects the plasma cells. Plasma cells are white blood cells that form part of your immune system. Plasma cells (also known as B-cells) produce antibodies. Immunoglobulins, or antibodies, aid in the fight against infection.
Multiple myeloma develops when healthy cells become abnormal and multiply, producing abnormal antibodies known as M proteins. This alteration triggers a chain reaction of medical problems and illnesses that can harm your bones, kidneys, and body's capacity to produce healthy white and red blood cells and platelets.
Early in multiple myeloma, there may be no symptoms. When signs and symptoms occur, they may include:
Cancer staging provides the foundation for treatment. The staging approach for multiple myeloma begins by classifying the condition into one of four categories:
Causes
Healthcare practitioners and researchers are unsure what causes multiple myeloma. Some probable causes they're looking into include:
Risk Factors
The following factors may raise the risk of multiple myeloma:
Complications
The complications of multiple myeloma include:
Some preventative tips for multiple myeloma:
These strategies can help manage risk factors and encourage early detection.
Treatments may include:
Targeted therapy: Therapy with a specific goal in mind. Targeted therapy employs medications that target specific molecules in cancer cells. Targeted medications that block these molecules can kill cancer cells.
Cost Start From USD 3500Explore Options
Immunotherapy: Immunotherapy is a medicine-based treatment that stimulates the immune system to attack cancer cells.
Cost Start From USD 3000 - USD 13578Explore Options
CAR-T cell therapy: Chimeric antigen receptor T cell treatment, also known as CAR-T cell therapy, prepares your immune system cells to combat multiple myeloma. This treatment starts by removing some white blood cells, especially T cells, from your blood. The cells are transferred to a laboratory. In the lab, cells are treated to produce specific receptors. The receptors aid cells recognise a marker on the surface of myeloma cells.
Cost Start From USD 150000 - USD 470000Explore Options
Chemotherapy: It is a treatment that uses strong medications to kill cancer cells. The medicines kill rapidly growing cells, including myeloma cells.
Cost Start From USD 1000 - USD 6800Explore Options
Bone marrow transplants: A bone marrow transplant, also known as a stem cell transplant, involves replacing damaged bone marrow with healthy bone marrow.
Cost Start From USD 50000 - USD 80000Explore Options
Radiation therapy: Radiation therapy uses high-energy beams to attack cancer cells. Energy can be derived from X-rays, protons, or other sources.
The following tests and procedures diagnose multiple myeloma:
Multiple myeloma rehabilitation focuses on enhancing quality of life, symptom management, and physical and mental recovery. Here are some main rehab options:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Bangkok, Thailand
Bangkok Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Thailand:
Yes, a bone marrow transplant (also known as stem cell transplant) is an option for treating multiple myeloma in Thailand.
Based on the patient's condition, leading hospitals in the country provide autologous and allogeneic stem cell transplants.
These treatments are conducted by highly skilled haematologists and oncologists, who use cutting-edge technology to ensure the best possible patient outcomes.
The stage of the disease determines the prognosis for multiple myeloma in Thailand, the patient's overall health, and the response to treatment. Many patients benefit from sophisticated treatment choices such as chemotherapy, immunotherapy, and stem cell transplants, which allow for more prolonged remissions and a higher quality of life. Early diagnosis and individualised treatment options improve disease management in Thailand.
Yes, numerous leading hospitals in Thailand are doing clinical studies for multiple myeloma, looking into novel treatments such as immunotherapy, gene therapies, and novel medication combinations. These trials provide patients with cutting-edge treatments while also helping to advance our understanding and treatment of multiple myeloma. Patients can contact these facilities to learn about available clinical trials and novel treatment alternatives.
Treating multiple myeloma during pregnancy requires a careful, individualised approach, as many standard treatments are contraindicated. In such circumstances, doctors would closely evaluate the mother's and baby's health and consider the safest treatment alternatives during pregnancy.
Immunotherapy is a promising treatment option for multiple myeloma. In Thailand, immune checkpoint inhibitors and monoclonal antibodies assist the immune system in targeting and destroying malignant cells.
The survival rate for multiple myeloma in Thailand varies according on the illness stage and the patient's overall health. Many patients benefit from advanced treatment choices, which improve their quality of life and increase their chances of survival.
In Thailand, autologous stem cell transplants (ASCT) employ the patient's cells, whereas allogeneic stem cell transplants use donor cells. Both procedures are available in specialised centres for the treatment of multiple myeloma.
Yes, advanced multiple myeloma can still be treated with immunotherapy, targeted treatments, and stem cell transplantation. Palliative treatment is also available to alleviate symptoms and improve quality of life.

Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026